검색
Repligen Corp
RGEN관심 목록에 추가
136.308USD
-0.692-0.51%
시장 운영 시간 （ET）시세는 15분 지연됩니다
7.68B시가총액
149.22P/E TTM
자세한 내용은 Repligen Corp 회사
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Repligen Corp 정보
종목 코드 RGEN
회사 이름Repligen Corp
상장일Apr 29, 1986
CEOLoeillot (Olivier)
직원 수1778
유형Ordinary Share
회계 연도 종료Apr 29
주소Building 1, Suite 100
도시WALTHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02453
전화17814499560
웹사이트https://www.repligen.com/
종목 코드 RGEN
상장일Apr 29, 1986
CEOLoeillot (Olivier)
Repligen Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
92.82K
+1.07%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
40.05K
+8.56%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
9.42K
-28.60%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
5.44K
+18.30%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
5.01K
+19.84%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.22K
-155.54%
Mr. Tony John Hunt
Mr. Tony John Hunt
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
Independent Director
Independent Director
--
--
Mr. James R. Bylund
Mr. James R. Bylund
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Konstantin Konstantinov, Ph.D.
Dr. Konstantin Konstantinov, Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
92.82K
+1.07%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
40.05K
+8.56%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
9.42K
-28.60%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
5.44K
+18.30%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
5.01K
+19.84%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.22K
-155.54%
자주 묻는 질문
Repligen Corp의 상위 5대 주주는 누구인가요?
Repligen Corp의 상위 5대 주주는 다음과 같습니다: Ms. Karen A. Dawes
Repligen Corp(RGEN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Repligen Corp의 주식을 보유한 기관은 총 1067곳이며, 이들이 보유한 주식의 총 가치는 약 65.93M로 전체 발행 주식의 116.89%를 차지합니다. 이는 2025Q4 대비 -2643397.00 증가한 수치입니다.
Repligen Corp의 최대 수익원은 무엇인가요?
2026Q1 기준, Repligen Corp의 Product revenue - Filtration products 부문이 가장 높은 매출을 기록했으며, 금액은 402.79M로 전체 매출의 54.58%를 차지했습니다.
